NewGLab Pharma launches anticancer supplement 'Cofactor One'... "Targeting global market"

[Asia Economy Reporter Hyunseok Yoo] NewGLab Pharma announced on the 16th that its U.S. subsidiary, NewGLab Pharma, Inc., has officially started selling three newly launched ‘CoFactorOne Advanced’ products. CoFactorOne is a health supplement developed based on the research of Dr. Younghee Ko, a leading authority in the field of anticancer agents.

CoFactorOne was developed as an anticancer supplement that not only improves fatigue related to cancer treatment (Cancer Related Fatigue) but also enhances weakened immunity to aid in anticancer effects. Made from natural ingredients, it is suitable for anyone seeking to strengthen their immune system.

The main ingredients of CoFactorOne are plant-derived natural compounds such as ‘flavonoids’ and ‘polyphenols,’ which have anticancer and antioxidant effects. Additionally, it contains ingredients like ‘Luteolin,’ which has anti-inflammatory properties, and ‘Rutin,’ which strengthens blood vessels. The newly launched ‘Advanced’ line includes added ‘Resveratrol,’ which lowers serum cholesterol, and ‘Quercetin,’ which helps conserve vitamin C.

The newly released ‘Advanced’ line consists of one tablet form and two powder products with flavors of chocolate and vanilla. The powder products were created for elderly people and patients who have difficulty swallowing pills, but they are carefully designed for both nutrition and taste, making them easy to consume for people of all ages. Moreover, the chocolate and vanilla powders also contain vegetarian protein extracted from almonds and coconut milk.

A representative from NewGLab Pharma stated, “Following the steady sales of the tablet form CoFactorOne launched last year, we have upgraded the main ingredients and diversified the intake methods by adding a powder product lineup. Based on reliable product quality, we plan to continuously expand our brand presence in the global anticancer supplement market, which is worth approximately 13 trillion KRW, and are also exploring sales strategies in regions outside the U.S., including Korea.”

Currently, CoFactorOne products are sold on the NewGLab Pharma website in the U.S., and various promotions are underway in conjunction with the launch of the new products.

This content was produced with the assistance of AI translation services.